Dr. Jintanat Ananworanich is a pediatrician and clinical immunologist with a broad background in translational medicine and clinical trials. She is currently the Medical Lead for the Moderna Influenza Vaccine program. She joined Moderna in May 2021 and is currently Executive Director in Clinical Development, Infectious Diseases based in Cambridge, Massachusetts. She previously was a clinical lead for the RSV program at the Bill & Melinda Gates Medical Research Institute.  For almost two decades, Dr. Ananworanich led HIV clinical research at the Thai Red Cross AIDS Research Center in Bangkok and at the US Military HIV Research Program in Maryland. She initiated and directed the highly successful RV254 acute HIV study in Thailand that elevated the understanding of early events in HIV infection and pioneered HIV cure research.  She has published over 350 articles in peer-reviewed journals.  Dr. Ananworanich is currently Professor of Medicine at the Department of Global Health, the University of Amsterdam. She serves on the board of the AIDS Vaccine Advocacy Coalition.